Surgery Partners (NASDAQ:SGRY) Given “Buy” Rating at Benchmark
Benchmark reissued their buy rating on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research report released on Monday,Benzinga reports. Benchmark currently has a $35.00 price target on the stock. Several other research analysts have also recently commented on SGRY. Royal Bank of Canada reiterated an “outperform” rating and issued a $35.00 price […]
Benchmark reissued their buy rating on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research report released on Monday,Benzinga reports. Benchmark currently has a $35.00 price target on the stock. Several other research analysts have also recently commented on SGRY. Royal Bank of Canada reiterated an “outperform” rating and issued a $35.00 price […]